Literature DB >> 15967966

Can NSAIDs contribute to Alzheimer's disease?

David Secko.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967966      PMCID: PMC1150254          DOI: 10.1503/cmaj.050601

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.

Authors:  S Weggen; J L Eriksen; P Das; S A Sagi; R Wang; C U Pietrzik; K A Findlay; T E Smith; M P Murphy; T Bulter; D E Kang; N Marquez-Sterling; T E Golde; E H Koo
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

2.  Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production.

Authors:  Thomas Kukar; Michael Paul Murphy; Jason L Eriksen; Sarah A Sagi; Sascha Weggen; Tawnya E Smith; Thomas Ladd; Murad A Khan; Rajashaker Kache; Jenny Beard; Mark Dodson; Sami Merit; Victor V Ozols; Panos Z Anastasiadis; Pritam Das; Abdul Fauq; Edward H Koo; Todd E Golde
Journal:  Nat Med       Date:  2005-04-17       Impact factor: 53.440

3.  Killing pain, killing neurons?

Authors:  Tony Wyss-Coray
Journal:  Nat Med       Date:  2005-05       Impact factor: 53.440

  3 in total
  2 in total

Review 1.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

2.  Possible mechanisms of action of NSAIDs and related compounds that modulate gamma-secretase cleavage.

Authors:  Thomas Kukar; Todd E Golde
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.